DOISS TABLET

THE SUPER SYNERGY

Composition

  • DOISS 625 – Amoxycillin 500mg + Clavulanic acid 125mg Tablets
  • DOISS 1000 – Amoxycillin 875mg+Clavulanic acid 125 mg Tablets

Description

  • Amoxicillin/clavulanate potassium is an antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium.
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin/clavulanate potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Indications

  • Lower Respiratory Tract Infections
  • Upper Respiratory Tract Infections
  • Otitis Media
  • Sinusitis
  • Soft Skin Tissue Infections
  • Urinary Tract Infections

DOISS / DOISS HS

THE SUPER SYNERGY

Composition

  • DOISS –Amoxycillin 200 mg+ Clavulanic acid 28.5 mg/ 5ml Dry Syrup
  • DOISS – Amoxycillin 400 mg + Clavulanic acid 57 mg/ 5ml Dry Syrup

Description

  • Amoxicillin/clavulanate potassium is an antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium.
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin/clavulanate potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Indications

  • Otitis Media

GUDRIF

THE SUPER SYNERGY

Composition

  • Rifaximin 400mg Tablets

Description

  • Rifaximin is a semisynthetic, rifamycin-based, non-systemic antibiotic, additional pyridoimidazole ring makes it virtually nonabsorbable, enabling it to achieve a high concentration in the gastrointestinal tract.
  • It inhibits RNA synthesis by binding to the β-subunit of bacterial DNA-dependent RNA polymerase. It is poorly absorbed and thus has a highly favorable safety profile.

Indications

  • Irritable Bowel Syndrome with diarrhea (IBS-D)
  • Traveler’s diarrhea caused by noninvasive strains of Escherichia coli.
  • Overt hepatic encephalopathy recurrence in patients ≥18 years of age.

EDVABACT CZ (1.5g)

THE SPECIALIST!

Composition

  • Cefoperazone 1000mg + Sulbactam 500mg Injection

Description

  • Cefoperazone, a 3rd generation cephalosporin antibiotic, inhibits bacterial cell wall synthesis of actively dividing cells by binding to one or more penicillin binding proteins (PBPs).
  • Sulbactam is a β-lactamase inhibitor and acts primarily by irreversible inactivation of β-lactamases.

Indications

  • Respiratory tract infections (upper and lower)
  • Urinary tract infections (upper and lower)
  • Intra-abdominal infections
  • Septicemia
  • Meningitis
  • Skin and soft tissue infections
  • Bone and joint infections
  • Pelvic inflammatory disease, endometritis, gonorrhea, and other infections of the genital tract

EDVABACT P

THE SPECIALIST!

Composition

  • Piperacillin 4g + Tazobactam 0.5g

Description

  • Piperacillin
    • - A broad-spectrum, semisynthetic penicillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis.
    • - In vitro, piperacillin is active against a variety of Gram-positive and Gram-negative aerobic and anaerobic bacteria.
  • Tazobactam
    • - A β-lactamase inhpibitor of the Molecular class A enzymes, including Richmond- Sykes class III (Bush class 2b & 2b') penicillinases and cephalosporinases.
    • - Tazobactam does not induce chromosomally mediated β-lactamases at tazobactam concentrations achieved with the recommended dosage regimen.

Indications

  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Intra-abdominal infections
  • Skin and skin structure infections
  • Pelvic infections